(Q34469061)

2 August 2017

1 reference

title

Remote neurologic manifestations of cancer (English)

1 reference

2 August 2017

Edward J Dropcho

1

1 reference

2 August 2017

publication date

1 February 2002

1 reference

2 August 2017

1 reference

2 August 2017

volume

20

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

85-122, vi

1 reference

Paraneoplastic temporal lobe epilepsy with testicular neoplasm and atypical amnesia

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Limbic encephalitis and small cell lung cancer. Clinical and immunological features

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Tumor-specific killer cells in paraneoplastic cerebellar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic cerebellar degeneration: clinical-immunological correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

[18F]fluorodeoxyglucose positron emission tomography in the diagnosis of cancer in patients with paraneoplastic neurological syndrome and anti-Hu antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Limbic encephalitis and immunological perturbations in two patients with thymoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Chronic inflammatory demyelinating polyneuropathy associated with carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Antineuronal Antibodies in Patients With Neuroblastoma and Paraneoplastic Opsoclonus-Myoclonus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

All-trans-retinoic acid in POEMS syndrome. Therapeutic effect associated with decreased circulating levels of proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Dermatomyositis and malignancy. A review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Immunoadsorption therapy for paraneoplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Stiffman syndrome: a rare paraneoplastic disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin: A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic opsoclonus-myoclonus secondary to malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Delayed diagnosis of Lambert-Eaton myasthenic syndrome in a patient presenting with recurrent refractory respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Anti-MAG antibody-associated polyneuropathies: improvement following immunotherapy with monthly plasma exchange and IV cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Coexistence of Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration: differential effects of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Subacute cerebellar degeneration associated with neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Degeneration of muscle in association with carcinoma of the bronchus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Neuroendocrine lung tumors and disorders of the neuromuscular junction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic limbic encephalopathy with testicular carcinoma. A reversible neurologic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Spontaneous neurological improvement in anti-Hu associated encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

A case of Hodgkin's lymphoma producing neuromyotonia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Anti-Ri antibodies associated with opsoclonus and progressive encephalomyelitis with rigidity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Association of small cell lung cancer and the anti-Hu paraneoplastic syndrome: radiographic and CT findings

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Lambert-Eaton Myasthenic Syndrome and Polyneuropathy in a Patient with Epidermoid Carcinoma of the Lung

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

"Limbic encephalitis" and its association with carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Reversal of subacute paraneoplastic cerebellar syndrome with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer?A quantitative western blot analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Subacute myelopathy: an unusual paraneoplastic complication of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies: clinical response to excision of the primary tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic limbic encephalitis in Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Evolution of brain MRI abnormalities in limbic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Peripheral neuropathy associated with Castleman's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Antineuronal (anti-Ri) antibodies in a patient with steroid-responsive opsoclonus-myoclonus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic opsoclonus-myoclonus. Association with medullary thyroid carcinoma and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Anti-Hu-associated paraneoplastic sensory neuropathy with peripheral nerve demyelination and microvasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Anti-Ri-associated paraneoplastic neurologic disorder without opsoclonus in a patient with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Neuropathy and IgM M-proteins: prognostic value of antibodies to MAG, SGPG, and sulfatide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic motor neuron disease and renal cell carcinoma: improvement after nephrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

A novel antineuronal antibody in a motor neuron syndrome associated with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

A reversible cause of hypercapnic respiratory failure: lower motor neuronopathy associated with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Motor neuron syndromes in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Lambert-Eaton myasthenic syndrome: I. Early morphological effects of IgG on the presynaptic membrane active zones

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Peripheral neuropathy in essential mixed cryoglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Subacute cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with antibodies to voltage-gated calcium channels: differential effect of immunosuppressive therapy on central and peripheral defects

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Lymphoproliferative disorders and motor neuron disease: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Indolent anti-Hu-associated paraneoplastic sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Localization of the neuronal antigen recognized by anti-Tr antibodies from patients with paraneoplastic cerebellar degeneration and Hodgkin's disease in the rat nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Uptake of systemically administered human anticerebellar antibody by rat Purkinje cells following blood-brain barrier disruption

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Heterogeneity of autoantibodies in stiff-man syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Trends in the association of Lambert-Eaton myasthenic syndrome with carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Neuromuscular, autonomic and central cholinergic hyperactivity associated with thymoma and acetylcholine receptor-binding antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

The carcinomatous neuromyopathy of oat cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Chorea resulting from paraneoplastic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Antibodies to ion-channel proteins in thymoma with myasthenia, neuromyotonia, and peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Encephalomyelitis with carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Ultrastructural localization of anti-Purkinje cell antibody-binding sites in paraneoplastic cerebellar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Poor outcome in patients with advanced stage neuroblastoma and coincident opsomyoclonus syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Ulip/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic opsomyoclonus, cerebellar ataxia and encephalopathy associated with anti-Purkinje cell antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic myelopathy at diagnosis in a patient with pathologic stage 1A Hodgkin disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Limbic encephalitis associated with thymoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic vasculitis of nerve: A remote effect of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Anti-Ri positive opsoclonus-myoclonus-ataxia in ovarian duct cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic opsoclonus-myoclonus in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Osteosclerotic myeloma and peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Autonomic dysfunction in Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Expression of Hel-N1 and Hel-N2 in small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Mammalian homologs of Drosophila ELAV localized to a neuronal subset can bind in vitro to the 3' UTR of mRNA encoding the Id transcriptional repressor

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Magnetic resonance imaging of limbic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic opsoclonus associated with papillary renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Adverse effect of verapamil in a patient with the Lambert-Eaton syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Autopsy report of acute necrotizing opticomyelopathy associated with thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Long term melphalan-prednisolone chemotherapy for POEMS syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Polymyositis-dermatomyositis and malignant lesions: does an association exist?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Lambert-Eaton myasthenic syndrome: immunoglobulin G inhibition of Ca2+ flux in tumor cells correlates with disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

The role of autoantibodies in Lambert-Eaton myasthenic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Necrotizing Myelopathy Complicating Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic necrotizing myopathy: clinical and pathological features

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic pseudo-obstruction, mononeuropathy multiplex, and sensory neuronopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic Encephalomyelitis Antigens Bind to the AU-rich Elements of mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Distribution of electrophysiological abnormality in Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

NECROTIZING MYELOPATHY ASSOCIATED WITH VISCERAL CARCINOMA

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Hu antigens: Reactivity with hu antibodies, tumor expression, and major immunogenic sites

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

A randomised double blind trial versus placebo does not confirm the benefit of alpha-interferon in polyneuropathy associated with monoclonal IgM.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

A randomised clinical trial comparing interferon-alpha and intravenous immunoglobulin in polyneuropathy associated with monoclonal IgM. The IgM-associated Polyneuropathy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Neuromyotonia, peripheral neuropathy and myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Opsoclonus-ataxia due to childhood neural crest tumors: a chronic neurologic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

An improved diagnostic assay for Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Lambert-Eaton myasthenic syndrome IgG depletes presynaptic membrane active zone particles by antigenic modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

The Crow-Fukase syndrome: a study of 102 cases in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Specificity of omega-conotoxin MVIIC-binding and -blocking calcium channel antibodies in Lambert-Eaton myasthenic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

CRYOGLOBULINAEMIC NEUROPATHY

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

A treatment algorithm for Lambert-Eaton myasthenic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Lambert-Eaton myasthenic syndrome presenting with severe respiratory failure

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Improvement of paraneoplastic opsoclonus-myoclonus after protein A column therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Reversible limbic encephalitis caused by ovarian teratoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

The Lambert-Eaton myasthenic syndrome. A review of 50 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome: serologic and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic vasculitis of the peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Anti-Hu-associated paraneoplastic sensory neuropathy responding to early aggressive immunotherapy: report of two cases and review of literature

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Electrophysiological and clinical correlations in the Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Low-dose guanidine and pyridostigmine: relatively safe and effective long-term symptomatic therapy in Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Necrotizing myelopathy associated with malignancy. A clinicopathologic study of two cases and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Cross-linking of presynaptic calcium channels: a mechanism of action for Lambert-Eaton myasthenic syndrome antibodies at the mouse neuromuscular junction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

A reversible neuronal antibody (anti-Tr) associated paraneoplastic cerebellar degeneration in Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Neuroblastoma-associated opsoclonus-myoclonus treated with intravenously administered immune globulin G

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Subacute sensory neuropathy associated with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Neurological sequelae of the dancing eye syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Treatment of Lambert-Eaton syndrome with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Omnipause neurons in two cases of opsoclonus associated with oat cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic limbic encephalitis in two teenage girls

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Stiff-man syndrome in a woman with breast cancer: an uncommon central nervous system paraneoplastic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Induction of anti-Purkinje cell antibodies in vivo by immunizing with a recombinant 52-kDa paraneoplastic cerebellar degeneration-associated protein

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Antineuronal antibody in a patient with neuroblastoma and opsoclonus-myoclonus-ataxia: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Lambert-Eaton myasthenic syndrome: clinical diagnosis, immune-mediated mechanisms, and update on therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

3,4-Diaminopyridine (DAP) in the treatment of Lambert-Eaton myasthenic syndrome (LEMS).

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Atypical stiff-person syndrome with spinal MRI findings, amphiphysin autoantibodies, and immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Subacute motor neuronopathy: a remote effect of lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Ofloxacin in the Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Epilepsia partialis continua: a new manifestation of anti-Hu-associated paraneoplastic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic stiff limb syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Acute ventilatory failure in Lambert-Eaton myasthenic syndrome and its response to 3,4-diaminopyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Autoantibodies in paraneoplastic cerebellar degeneration bind to cytoplasmic antigens of Purkinje cells in humans, rats and mice and are of multiple immunoglobulin classes

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Immunological and Clinical Response to Immunosuppressive Treatment in Paraneoplastic Cerebellar Degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Limbic encephalitis and antibodies to Ma2: a paraneoplastic presentation of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Chorea resulting from paraneoplastic striatal encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Clinical outcome in children with acute cerebellar encephalopathy and neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Lambert-Eaton myasthenic syndrome (LEMS). Clinical and electrodiagnostic features and response to therapy in 59 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Lambert-Eaton myasthenic syndrome: electrodiagnostic findings and response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Repetitive nerve stimulation studies in the Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Lambert-Eaton myasthenic syndrome without anti-calcium channel antibody: adverse effect of calcium antagonist diltiazem

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Non-Hodgkin malignant lymphomas and peripheral neuropathies—13 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Effect of steroid and high-dose immunoglobulin therapy on opsoclonus-myoclonus syndrome occurring in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Motor neuron disease: a paraneoplastic process associated with anti-hu antibody and small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Anti-Hu antibody titre and brain metastases before and after treatment for small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Nerve and muscle microvasculitis in peripheral neuropathy: a remote effect of cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Peripheral neuropathies and lymphoma without monoclonal gammopathy: a new classification

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Successful treatment of IgM paraproteinaemic neuropathy with fludarabine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Paraneoplastic encephalomyelitis and seminoma: importance of testicular ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

Anti-Hu-associated peripheral nerve and muscle microvasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900055-0

7 January 2021

10.1016/S0733-8619(03)00055-0

Identifiers

DOI

1 reference

2 August 2017

1 reference